VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Altered monocyte chemotactic and activating factor gene expression in human glioblastoma cell lines increased their susceptibility to cytotoxicity.
Low-dose interferon-alpha in chronic myeloid leukemia.
New chemotherapeutic agents in acute myeloid leukemia.
The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.
Mutant BCR-ABL clones in chronic myeloid leukemia.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mutant BCR-ABL clones in chronic myeloid leukemia.
Mutant BCR-ABL clones in chronic myeloid leukemia. Haematologica. 2011 Mar; 96(3):347-9.
View in:
PubMed
subject areas
Antineoplastic Protocols
Clinical Trials, Phase III as Topic
Clone Cells
Drug Resistance, Neoplasm
Fusion Proteins, bcr-abl
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Mutation
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Treatment Failure
authors with profiles
HAGOP M KANTARJIAN
JORGE E CORTES
ELIAS JOSEPH JABBOUR